Materialise NV Reports Q2 2024 Financial Results
Ticker: MTLS · Form: 6-K · Filed: Jul 31, 2024 · CIK: 1091223
| Field | Detail |
|---|---|
| Company | Materialise NV (MTLS) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-results, additive-manufacturing
Related Tickers: MTLS
TL;DR
MTLS dropped Q2 earnings report 7/31, check financials.
AI Summary
Materialise NV announced its second quarter 2024 financial results on July 31, 2024. The company, a leader in additive manufacturing and medical software, reported its financial performance for the period ending in July 2024.
Why It Matters
This filing provides investors with the latest financial performance data for Materialise NV, crucial for understanding the company's operational health and future prospects in the additive manufacturing sector.
Risk Assessment
Risk Level: low — This is a routine financial results announcement, not indicating any immediate operational or financial distress.
Key Players & Entities
- Materialise NV (company) — Registrant and reporting company
- NASDAQ:MTLS (company) — Stock ticker symbol
- July 31, 2024 (date) — Date of press release and filing
- Brigette de Vet-Veithen (person) — CEO of Materialise NV
- De Vet Management BV (company) — Affiliated entity of CEO
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose of this 6-K filing is to report the financial results of Materialise NV for the second quarter of 2024, as announced in a press release dated July 31, 2024.
When were the second quarter 2024 results announced?
The second quarter 2024 results were announced on July 31, 2024.
What is Materialise NV's stock ticker symbol?
Materialise NV's stock ticker symbol is MTLS, traded on NASDAQ.
Who signed the report on behalf of Materialise NV?
The report was signed by Brigette de Vet-Veithen, Chief Executive Officer of Materialise NV.
What type of company is Materialise NV?
Materialise NV is described as a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services.
Filing Stats: 141 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2024-07-31 07:36:13
Filing Documents
- tm2420473d1_6k.htm (6-K) — 11KB
- tm2420473d1_ex99-1.htm (EX-99.1) — 247KB
- 0001104659-24-084153.txt ( ) — 259KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-36515 Materialise NV Technologielaan 15 3001 Leuven Belgium (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit Description 99.1 Press Release dated July 31, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MATERIALISE NV By: /s/ Brigette de Vet-Veithen Name: Brigette de Vet-Veithen De Vet Management BV Title: Chief Executive Officer Date: July 31, 2024